103 related articles for article (PubMed ID: 30664119)
1. Associations Between Magnetic Resonance Imaging Findings and Clincopathologic Factors in Triple-Negative Breast Cancer.
Choi BB; Kim SH; Youn I
J Comput Assist Tomogr; 2019; 43(2):252-256. PubMed ID: 30664119
[TBL] [Abstract][Full Text] [Related]
2. Triple-negative breast cancer: Pretreatment magnetic resonance imaging features and clinicopathological factors associated with recurrence.
Lee YJ; Youn IK; Kim SH; Kang BJ; Park WC; Lee A
Magn Reson Imaging; 2020 Feb; 66():36-41. PubMed ID: 31785544
[TBL] [Abstract][Full Text] [Related]
3. Dynamic contrast enhanced-MRI and diffusion-weighted image as predictors of lymphovascular invasion in node-negative invasive breast cancer.
Choi BB
World J Surg Oncol; 2021 Mar; 19(1):76. PubMed ID: 33722246
[TBL] [Abstract][Full Text] [Related]
4. Association between rim enhancement of breast cancer on dynamic contrast-enhanced MRI and patient outcome: impact of subtype.
Schmitz AM; Loo CE; Wesseling J; Pijnappel RM; Gilhuijs KG
Breast Cancer Res Treat; 2014 Dec; 148(3):541-51. PubMed ID: 25376743
[TBL] [Abstract][Full Text] [Related]
5. Minimum apparent diffusion coefficient for predicting lymphovascular invasion in invasive cervical cancer.
Yang W; Qiang JW; Tian HP; Chen B; Wang AJ; Zhao JG
J Magn Reson Imaging; 2017 Jun; 45(6):1771-1779. PubMed ID: 27859961
[TBL] [Abstract][Full Text] [Related]
6. Rim sign and histogram analysis of apparent diffusion coefficient values on diffusion-weighted MRI in triple-negative breast cancer: Comparison with ER-positive subtype.
Choi Y; Kim SH; Youn IK; Kang BJ; Park WC; Lee A
PLoS One; 2017; 12(5):e0177903. PubMed ID: 28542297
[TBL] [Abstract][Full Text] [Related]
7. Imaging and histologic prognostic factors in triple-negative breast cancer and carcinoma in situ as a prognostic factor.
Sebastián Sebastián C; García Mur C; Cruz Ciria S; Rosero Cuesta DS; Gros Bañeres B
Radiologia; 2016; 58(4):283-93. PubMed ID: 27064084
[TBL] [Abstract][Full Text] [Related]
8. Quantitative apparent diffusion coefficient measurement obtained by 3.0Tesla MRI as a potential noninvasive marker of tumor aggressiveness in breast cancer.
Durando M; Gennaro L; Cho GY; Giri DD; Gnanasigamani MM; Patil S; Sutton EJ; Deasy JO; Morris EA; Thakur SB
Eur J Radiol; 2016 Sep; 85(9):1651-8. PubMed ID: 27501902
[TBL] [Abstract][Full Text] [Related]
9. Breast parenchymal signal enhancement ratio at preoperative magnetic resonance imaging: association with early recurrence in triple-negative breast cancer patients.
Park VY; Kim EK; Kim MJ; Yoon JH; Moon HJ
Acta Radiol; 2016 Jul; 57(7):802-8. PubMed ID: 26516288
[TBL] [Abstract][Full Text] [Related]
10. Preoperative MRI features associated with lymphovascular invasion in node-negative invasive breast cancer: A propensity-matched analysis.
Cheon H; Kim HJ; Lee SM; Cho SH; Shin KM; Kim GC; Park JY; Kim WH
J Magn Reson Imaging; 2017 Oct; 46(4):1037-1044. PubMed ID: 28370761
[TBL] [Abstract][Full Text] [Related]
11. Multiparametric diffusion-weighted imaging in breast lesions: Association with pathologic diagnosis and prognostic factors.
Suo S; Cheng F; Cao M; Kang J; Wang M; Hua J; Hua X; Li L; Lu Q; Liu J; Xu J
J Magn Reson Imaging; 2017 Sep; 46(3):740-750. PubMed ID: 28139036
[TBL] [Abstract][Full Text] [Related]
12. Retrospective analysis of the utility of multiparametric MRI for differentiating between benign and malignant breast lesions in women in China.
Fan WX; Chen XF; Cheng FY; Cheng YB; Xu T; Zhu WB; Zhu XL; Li GJ; Li S
Medicine (Baltimore); 2018 Jan; 97(4):e9666. PubMed ID: 29369183
[TBL] [Abstract][Full Text] [Related]
13. Role of diffusion-weighted imaging as an adjunct to contrast-enhanced breast MRI in evaluating residual breast cancer following neoadjuvant chemotherapy.
Hahn SY; Ko EY; Han BK; Shin JH; Ko ES
Eur J Radiol; 2014 Feb; 83(2):283-8. PubMed ID: 24315957
[TBL] [Abstract][Full Text] [Related]
14. Predictive Clinicopathologic and Dynamic Contrast-Enhanced MRI Findings for Tumor Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer.
Eom HJ; Cha JH; Choi WJ; Chae EY; Shin HJ; Kim HH
AJR Am J Roentgenol; 2017 Jun; 208(6):W225-W230. PubMed ID: 28350486
[TBL] [Abstract][Full Text] [Related]
15. Early Stage Triple-Negative Breast Cancer: Imaging and Clinical-Pathologic Factors Associated with Recurrence.
Bae MS; Moon HG; Han W; Noh DY; Ryu HS; Park IA; Chang JM; Cho N; Moon WK
Radiology; 2016 Feb; 278(2):356-64. PubMed ID: 26230976
[TBL] [Abstract][Full Text] [Related]
16. Research and progress in magnetic resonance imaging of triple-negative breast cancer.
Li J; Han X
Magn Reson Imaging; 2014 May; 32(4):392-6. PubMed ID: 24512798
[TBL] [Abstract][Full Text] [Related]
17. Diffusion-weighted imaging during MR-guided radiofrequency ablation of hepatic malignancies: analysis of immediate pre- and post-ablative diffusion characteristics.
Hoffmann R; Rempp H; Schraml C; Schwenzer N; Grözinger G; Blumenstock G; Rothgang E; Pereira PL; Claussen CD; Clasen S
Acta Radiol; 2015 Aug; 56(8):908-16. PubMed ID: 25182804
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment MR Imaging Features of Triple-Negative Breast Cancer: Association with Response to Neoadjuvant Chemotherapy and Recurrence-Free Survival.
Bae MS; Shin SU; Ryu HS; Han W; Im SA; Park IA; Noh DY; Moon WK
Radiology; 2016 Nov; 281(2):392-400. PubMed ID: 27195438
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Multifocality and Multicentricity With Breast Magnetic Resonance Imaging in Each Breast Cancer Subtype.
Prochowski Iamurri A; Ponziani M; Macchini M; Fogante M; Pistelli M; De Lisa M; Berardi R; Giuseppetti GM
Clin Breast Cancer; 2018 Apr; 18(2):e231-e235. PubMed ID: 29196020
[TBL] [Abstract][Full Text] [Related]
20. Diffusion-weighted imaging and (18) F-fluorodeoxyglucose positron emission tomography/computed tomography in breast cancer: Correlation of the apparent diffusion coefficient and maximum standardized uptake values with prognostic factors.
Karan B; Pourbagher A; Torun N
J Magn Reson Imaging; 2016 Jun; 43(6):1434-44. PubMed ID: 26663655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
